Skip to main content

Longeveron Inc.

LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001721484

No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Longeveron Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of LGVN: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders1221+9
Shares49.8K331.3K+281.5K (+565.6%)
Value$161.7K$534.1K+$372.3K (+230.2%)

New holders (12)

Institutions that held Longeveron Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to LGVN in Q2 2024
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC146,700$236.2K0.00%
Two Sigma Investments, LP46,041$74.1K0.00%
Geode Capital Management, LLC30,994$49.9K0.00%
Capital Investment Advisory Services, LLC26,525$42.7K0.00%
Citadel Advisors LLC22,485$36.2K0.00%
Squarepoint Ops LLC17,831$28.7K0.00%
Vontobel Holding Ltd.10,000$16.1K0.00%
Bank of America Corp1,682$2.71K0.00%
EverSource Wealth Advisors, LLC481$1.51K0.00%
Qube Research & Technologies Ltd100$1610.00%
Naples Money Management LLC100$1570.00%
FMR LLC1$20.00%

Sold out (3)

Institutions that held Longeveron Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of LGVN in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Vanguard Group Inc24,132$78.4K
JPMorgan Chase & Co129$419
Householder Group Estate & Retirement Specialist, LLC10$33